How SeaStar Medical’s ($ICU) Device QUELIMMUNE Is Transforming Treatment For Children With AKI

Benzinga 2025-06-27

Views 78

Dr. Kevin Chung, Chief Medical Officer at SeaStar Medical Holding Corporation Get Free Report and Dr. Stuart L. Goldstein, MD, from Cincinnati Children’s Hospital Medical Center, were recently guests on Benzinga’s All-Access.

The two were on hand to discuss QUELIMMUNE, SeaStar Medical's humanitarian medical device that was granted U.S. FDA approval to treat pediatric patients with acute kidney injury (AKI) due to sepsis or a septic condition. Dr. Goldstein was the chief investigator for the two studies that led to the FDA approval

Share This Video


Download

  
Report form
RELATED VIDEOS